Catalyst Pharmaceuticals, Inc. (CPRX) Stock

Catalyst Pharmaceuticals, Inc. (CPRX) is a Healthcare stock trading at $31.38 (as of 2026-06-18), with a market capitalization of $3.82B and a trailing P/E of 18.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuromuscular and neurological diseases in the United States. Its products include Firdapse (amifampridine phosphate) and Ruzurgi, with additional development programs in indications such as myasthenia gravis and spinal muscular atrophy type 3.

Valuation — source: SEC EDGAR (first-party)
Price$31.38
Market Cap$3.82B
P/E Ratio18.1
EV / EBITDA11.5
Price / Book3.79
Price / Sales6.43
DCF Value (model)$48.82
DCF Upside vs Price55.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$588.99M
Net Margin36.4%
Return on Equity21.9%
Current Ratio7.10
Revenue Growth (YoY)19.8%
EPS Growth (YoY)26.8%
FCF Growth (YoY)-12.8%
Financial Health — source: SEC EDGAR
Altman Z-Score18.10 (safe)
Valuation vs Sector & Industry
Stock P/E18.1
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-13.5%
vs Industry5.0%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($464.86M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORichard John Daly
Employees181
CountryUS
IPO Date2006-11-08

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • IDEAYA Biosciences, Inc. (IDYA)
  • Nuvation Bio Inc. (NUVB)
  • Disc Medicine, Inc. (IRON)
  • Arcus Biosciences, Inc. (RCUS)
  • Mineralys Therapeutics, Inc. (MLYS)
  • Prestige Consumer Healthcare Inc. (PBH)
  • Supernus Pharmaceuticals, Inc. (SUPN)
  • Beam Therapeutics Inc. (BEAM)
CPRX earnings history · CPRX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.